Nexien BioPharma Inc. services

Nexien BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration ("FDA") protocols, for a number of pharmaceutical formulations that include cannabinoids.

Nexien has an expanding intellectual property portfolio of exclusive licensed technology, provisional patents, and certain allowed patents, for the use of cannabinoids as pharmaceutical API`s for the treatment of targeted medical conditions.

This website contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995.